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The enzymatic pathways leading to the synthesis of bioactive steroids in the brain are now
almost completely elucidated in various groups of vertebrates and, during the last decade,
the neuronal mechanisms involved in the regulation of neurosteroid production have
received increasing attention. This report reviews the current knowledge concerning the
effects of neurotransmitters, peptide hormones, and neuropeptides on the biosynthesis of
neurosteroids. Anatomical studies have been carried out to visualize the neurotransmitter-
or neuropeptide-containing ﬁbers contacting steroid-synthesizing neurons as well as the
neurotransmitter, peptide hormones, or neuropeptide receptors expressed in these neu-
rons. Biochemical experiments have been conducted to investigate the effects of neuro-
transmitters, peptide hormones, or neuropeptides on neurosteroid biosynthesis, and to
characterize the type of receptors involved. Thus, it has been found that glutamate, acting
through kainate and/or AMPA receptors, rapidly inactivates P450arom, and that melatonin
produced by the pineal gland and eye inhibits the biosynthesis of 7α-hydroxypregnenolone
(7α-OH- 5Δ P), while prolactin produced by the adenohypophysis enhances the formation
of 7α-OH- 5Δ P. It has also been demonstrated that the biosynthesis of neurosteroids is
inhibited by GABA, acting through GABAA receptors, and neuropeptide Y, acting through
Y1 receptors. In contrast, it has been shown that the octadecaneuropetide ODN, acting
through central-type benzodiazepine receptors, the triakontatetraneuropeptideTTN, acting
though peripheral-type benzodiazepine receptors, and vasotocin, acting through V1a-like
receptors, stimulate the production of neurosteroids. Since neurosteroids are implicated in
the control of various neurophysiological and behavioral processes, these data suggest that
some of the neurophysiological effects exerted by neurotransmitters and neuropeptides
may be mediated via the regulation of neurosteroid production.
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INTRODUCTION
The regulatory effects of steroid hormones in the central nervous
system (CNS) have long been recognized (McEwen, 1994; Baulieu
et al., 1999; Dubrovsky, 2005; Leskiewicz et al., 2006). Steroids
acting on the CNS originate from two sources: (1) steroids pro-
duced by peripheral endocrine glands, i.e., gonads, adrenal, and
placenta, that have to cross the blood–brain barrier to act on the
brain, are usually designated as neuroactive steroids; (2) steroids
directly synthesized within the CNS, either de novo from choles-
terol or by in situ metabolism of circulating steroid precursors, are
designated by the generic term neurosteroids (Robel and Baulieu,
1985, 1994; Baulieu, 1997, 1998). The capability of the nervous sys-
tem to synthesize steroids was originally discovered in mammals
(Corpéchot et al., 1981, 1983; Lanthier and Patwardhan, 1986)
and was subsequently generalized in other vertebrates including
birds, amphibians, and ﬁsh (Mensah-Nyagan et al., 1999; Mellon
and Vaudry, 2001; Tsutsui et al., 2003, 2009; Do Rego et al., 2009;
Diotel et al., 2010) indicating that de novo neurosteroidogenesis is
a conserved property in the vertebrate phylum.
There is growing evidence that neurosteroids play an impor-
tant role as endogenous modulators of neuronal functions and
behavioral processes, and that alterations of neurosteroid con-
centrations may contribute to the pathophysiology of neuronal
disorders (Majewska, 1992; Robel et al., 1999; Rupprecht and
Holsboer, 1999; Lapchak et al., 2000; Lapchak and Araujo, 2001;
Rupprecht et al., 2001; Dubrovsky, 2005; Belelli et al., 2006; Strous
et al., 2006). For instance, in rat, infusion of pregnenolone sul-
fate (Δ5PS) and dehydroepiandrosterone sulfate (DHEAS) into
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the nucleus basalis magnocellularis enhances learning and mem-
ory (Mayo et al., 1993; Robel et al., 1995). Reciprocally, deﬁcit in
cognitive performances in aged rats and mice is correlated with
low Δ5PS and DHEAS levels in the hippocampus (Flood et al.,
1988, 1992; Vallée et al., 1997, 2001; Ladurelle et al., 2000). In
chickens, administration of DHEA and DHEAS enhances learn-
ing and memory (Migues et al., 2002). In humans, DHEA and
DHEAS are considered to play a role in memory both in nor-
mal subjects and aging patients (Sunderland et al., 1989; Nasman
et al., 1991; Strous et al., 2006). More speciﬁcally, with regards
to Alzheimer’s disease, decreased levels of several neurosteroids
have been observed in the frontal cortex, hippocampus, amygdala,
striatum, hypothalamus, and cerebellum (Sunderland et al., 1989;
Nasman et al., 1991; Weill-Engerer et al., 2002; Schumacher et al.,
2003). The best known role of neurosteroids is their involvement
in the control of mood disorders. Numerous behavioral inves-
tigations have shown that neurosteroids exert anxiolytic (Hodge
et al., 2002; Strous et al., 2003), anti-depressant (Uzunova et al.,
2003; van Broekhoven and Verkes, 2003), anti-aggressive (Kava-
liers and Kinsella, 1995; Pinna et al., 2008), hypnotic (Lancel
et al., 1997; Damianisch et al., 2001), anti-convulsive (Landgren
et al., 1987; Belelli et al., 1989), and anti-stress actions (Patchev
et al., 1996; Hu et al., 2000). In animal models, an effect of
neurosteroids in eating disorders has been reported (Reddy and
Kulkarni, 1998, 1999; Strous et al., 2006). In particular, DHEA
decreases food intake (Svec and Porter, 1996; Svec et al., 1998),
reduces insulin resistance (Svec and Porter, 1998a,b), and lowers
adiposity (Svec and Porter, 1998a,b; Pham et al., 2000). DHEAS
has also been found to induce a signiﬁcant decrease in food
intake and body weight (Reddy and Kulkarni, 1999; Kaur and
Kulkarni, 2001). In contrast, allopregnanolone causes hyperpha-
gia in male and female rats (Reddy and Kulkarni, 1999). The
dose-dependent effects of Δ5PS on locomotion of mice placed
in a novel environment show the existence of a possible role of
neurosteroids in adaptation to novelty (Fahey et al., 1995a). Neu-
rosteroids are also involved in the regulation of excitotoxic and
apoptotic processes (Kimonides et al., 1999; Frank and Sagratella,
2000; Manji et al., 2003; Charalampopoulos et al., 2004; Wojtal
et al., 2006). In vivo studies indicate that progesterone, allopreg-
nanolone, and DHEA exert neuroprotective effects in models of
traumatic brain injury (Stein, 2001; Malik et al., 2003; Djebaili
et al., 2004; He et al., 2004) and in focal cerebral ischemia (Malik
et al., 2003; Sayeed et al., 2006). In vitro data also point to the
neuroprotective effects of neurosteroids in models of neuronal
injury against neurotoxic insults inﬂicted by excitatory amino
acids (Kimonides et al., 1999; Gursoy et al., 2001) and β-amyloid
peptides (Kimonides et al., 1998, 1999; Frank and Sagratella,
2000; Lockhart et al., 2002; Xilouri and Papazaﬁri, 2006). It
has been demonstrated that neurosteroids play important func-
tions in neurodevelopment and neuronal remodeling, including
neurogenesis (Roberts, 1986; Weaver et al., 1997; Schumacher
et al., 2000; Magnaghi et al., 2001; Young, 2002), axonal and
dendritic growth, and synaptic connectivity (Jones, 1994; Com-
pagnone and Mellon, 1998). In addition to their protective effects
on the brain, neurosteroids can regulate myelin formation and
increase expression of myelin proteins in the sciatic nerve (Koenig
et al., 1995; Murakami et al., 2000; Plassart-Schiess and Baulieu,
2001; Laurine et al., 2003; Melcangi et al., 2003; Iwata et al.,
2005).
The effects of neurosteroids on neuronal activity are mediated
through several distinct categories of receptors. Neurosteroids,
like other steroid hormones, can act at the transcriptional level
through interaction with nuclear receptors (McEwen, 1994; Rup-
precht, 1997;Mo et al., 2004).Neurosteroidsmay also interact with
plasma membrane G protein-coupled receptors either directly
(Schiess and Partridge, 2005; Tasker et al., 2006) or indirectly
by modulating the binding of neuropeptides to their receptors
(Grazzini et al., 1998; Zwain et al., 2002; Torres and Ortega, 2003).
In addition, neurosteroids can stimulate tubulin polymerization
in cultured neurons by binding to the microtubule-associated
protein-2 (Murakami et al., 2000; Plassart-Schiess and Baulieu,
2001; Laurine et al., 2003; Iwata et al., 2005). However,most of the
actions of neurosteroids are mediated via allosteric modulation
of neurotransmitter receptors, including the GABAA/central-type
benzodiazepine receptor (CBR) complex (Belelli and Lambert,
2005; Belelli et al., 2006; Zheng, 2009), N -methyl-d-aspartate
(NMDA; Mameli et al., 2005; Monnet and Maurice, 2006), kainate
(Costa et al., 2000; Dubrovsky, 2005), α-amino-3-hydroxy-5-
methyl-4-isoxazole-propionic acid (AMPA; Rupprecht and Hols-
boer, 2001; Dubrovsky, 2005), glycine (Jiang et al., 2006; Mitchell
et al., 2007), sigma (Monnet et al., 1995; Maurice et al., 2006),
serotonergic (Kostowski and Bienkowski, 1999; Shannon et al.,
2005a,b), nicotinic (Valera et al., 1992; Bullock et al., 1997), and
muscarinic receptors (Horishita et al., 2005; Steffensen et al.,
2006). For example, the effects of GABA on the GABAA receptor
are allosterically potentiated by progesterone and deoxycorticos-
terone metabolites such as allopregnanolone, pregnanolone, and
tetrahydrodeoxycorticosterone (Majewska et al., 1986; Majewska,
1992; Paul and Purdy, 1992; Bergeron et al., 1996). On the other
hand, Δ5PS and DHEA have been reported to inhibit GABAA
receptor activity (Majewska and Schwartz, 1987; Park-Chung
et al., 1999). Allopregnanolone is a negative modulator of the
NMDA receptors (Wu et al., 1991; Bowlby, 1993). In contrast,
Δ5PS and DHEA potentiate several NMDA-receptor-mediated
responses, and thus act as excitatory neurosteroids (Wu et al.,
1991; Irwin et al., 1992; Fahey et al., 1995b; Compagnone and
Mellon, 1998). At the AMPA and kainate receptors, Δ5PS behaves
as a negative modulator (Rupprecht, 1997; Mellon and Grif-
ﬁn, 2002). It has also been demonstrated that DHEAS acts as a
sigma receptor agonist, Δ5PS as a sigma receptor inverse agonist,
and progesterone as a sigma receptor antagonist (Monnet et al.,
1995).
The biochemical pathways leading to the synthesis of steroids
in the nervous system of vertebrates have now been almost com-
pletely elucidated (Tsutsui andYamazaki, 1995; Tsutsui et al., 1999;
Compagnone and Mellon, 2000; Do Rego et al., 2009; Diotel
et al., 2011; Vaudry et al., 2011) and it is now ﬁrmly established
that neurosteroids regulate neuronal activity (Reddy, 2003, 2010;
Dubrovsky, 2005; Belelli et al., 2006; Strous et al., 2006). Over
the last decade, a number of studies have thus been undertaken
to decipher the neuronal mechanisms involved in the regulation
of neurosteroid production. In the present report, we review the
current knowledge regarding the effects and mode of action of
neurotransmitters, peptide hormones, and neuropeptides on the
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biosynthesis of neurosteroids in the CNS of vertebrates. Remark-
ably, most of these studies have been conducted in the brain of
amphibians and birds. In fact, since the rate of steroid synthesis is
relatively high in the CNS of frog, quail, and zebra ﬁnch (Mensah-
Nyagan et al., 1994, 1996; Tsutsui et al., 2006, 2009; Do Rego et al.,
2007a; Schlinger and Remage-Healey, 2011), these animals have
proved to be suitable models in which to investigate the neuronal
mechanisms regulating neurosteroid production.
EFFECT OF GLUTAMATE ON NEUROSTEROID BIOSYNTHESIS
In the quail forebrain, all classes of ionotropic glutamate recep-
tors, i.e., NMDA, AMPA, and kainate receptors, are expressed
in the medial preoptic nucleus, a region which is enriched with
P450arom-containing cell bodies (Cornil et al., 2000), suggest-
ing that these neurons may be regulated by glutamate. Consis-
tent with this hypothesis, incubation of quail hypothalamic frag-
ments with AMPA and kainate, and to a certain extent NMDA,
inhibits P450arom activity (Balthazart et al., 2001a). In mice,
administration of NMDA or glutamate within the nidopallium
provokes a substantial decrease in the local concentration of estra-
diol (Remage-Healey et al., 2008; Cornil, 2009). These observa-
tions indicate that, in birds and mammals, glutamate exerts an
inhibitory action on the formation of neuroestrogens. In the quail
brain, the inhibitory effects of AMPA and kainate are mimicked by
ATP, Ca2+ and Mg2+, and the Ca2+ response is abrogated by PKA,
PKC, and CAMK (Balthazart et al., 2001b, 2003). Since P450arom
possesses several concensus phosphorylation sites in its sequence
(Harada, 1988; Balthazart et al., 2003), it appears that the rapid
inhibitory effect of AMPA, kainate, or NMDA on P450arom activ-
ity can be ascribed to Ca2+-dependent phosphorylation of the
P450arom protein (Balthazart et al., 2001c, 2003).
EFFECT OF MELATONIN ON NEUROSTEROID BIOSYNTHESIS
Measurement of neurosteroid content and/or biosynthesis in the
brain of vertebrates has revealed that marked changes in Δ5P,
7α-hydroxypregnenolone (7α-OH-Δ5P), P, THP, and Δ5PS occur
during circadian and seasonal cycles (Jo et al., 1990; Takase et al.,
1999; Inai et al., 2003; Matsunaga et al., 2004; Tsutsui et al., 2008).
These changes often parallel or mirror variations in plasma mela-
tonin concentrations (Hau and Gwinner, 1994; Warren and Cas-
sone, 1995; Marumoto et al., 1996; Murakami et al., 2001). It has
been shown that melatonin regulates locomotor activity in house
sparrow, Japanese quail, red-bellied newt, ural owl, rock pigeon,
andSpragueDawley rat (Hau andGwinner,1994;Warren andCas-
sone, 1995; Murakami et al., 2001). 7α-OH-Δ5P, in very much the
same as melatonin, regulates locomotor activity in Japanese quail
and red-bellied newt (Matsunaga et al., 2004; Tsutsui et al., 2008),
suggesting that melatonin may control 7α-OH-Δ5P production.
In support of this notion, male quails which exhibit marked diur-
nal variations in locomotor activity also show substantial changes
in brain level of 7α-OH-Δ5P while female quails which do not
show locomotor rhythms have low level of 7α-OH-Δ5P (Tsutsui
et al., 2008). Similarly, it has been found that the synthesis of 7α-
OH-Δ5P in the brain of male newts undergoes marked diurnal
changes with higher levels during the dark phase when locomo-
tor activity of males is high. In contrast, 7α-OH-Δ5P production
in female newts does not change (Haraguchi et al., 2009, 2010;
Koyama et al., 2009; Tsutsui et al., 2010). Inmale quail, suppression
of endogenous melatonin through pinealectomy (Px) and orbital
enucleation (Ex) causes a signiﬁcant increase of the expression of
CYP7B mRNA and biosynthesis of 7α-OH-Δ5P (Tsutsui et al.,
2008). ICV injection of melatonin suppresses the effects of Px and
Ex on CYP7B gene transcription and 7α-OH-Δ5P production.
Finally, the melatonin receptor antagonist luzindole abrogates the
inhibitory effect of melatonin on 7α-OH-Δ5P formation (Tsutsui
et al., 2008). Collectively, these data support the contention that, in
male birds, melatonin inhibits the expression of CYP7B and that
the subsequent decrease of 7α-OH-Δ5P in the brain is responsible
for the nocturnal reduction of locomotor activity.
EFFECT OF PROLACTIN ON NEUROSTEROID BIOSYNTHESIS
In male newts, as in many other wild animals, locomotor activ-
ity increases during the breeding season (Iwata et al., 2000).
This hyperlocomotor response is associated with a concomitant
increase in 7α-OH-Δ5P in the newt brain (Haraguchi et al., 2009,
2010). The pituitary hormone prolactin (PRL) exerts pleiotropic
functions in the control of reproduction in urodeles (Polzonetti-
Magni et al., 1995; Kikuyama et al., 2003). In particular, PRL is
involved in migration to water at the breeding season (Chadwick,
1941) and stimulates expression of courtship behavior with rapid
tail vibration by male newts (Toyoda et al., 1993). Indeed, in male
newts, plasma PRL concentration increases during the breeding
season (Matsuda et al., 1990; Mosconi et al., 1994) and it has
been shown that PRL acts centrally to activate courtship behav-
ior (Toyoda et al., 2005), suggesting that PRL may be involved
in the control of 7α-OH-Δ5P synthesis in the brain to increase
locomotor activity during the reproductive period. In support
of this hypothesis, PRL receptor immunoreactivity is observed
in CYP7B-expressing neurons in the anterior preoptic area (Poa)
and the magnocellular preoptic nucleus (Mg) of the newt brain
(Haraguchi et al., 2010). Hypophysectomymarkedly reduces brain
concentration and biosynthesis of 7α-OH-Δ5P in breeding male
newts and these effects are suppressed by ICV injection of PRL
(Haraguchi et al., 2010). Reciprocally, ICV administration of newt
PRL antiserumdose-dependently decreases 7α-OH-Δ5P synthesis
(Haraguchi et al., 2010). Taken together, these observations indi-
cate that PRL directly acts on Mg neurons expressing CYP7B to
enhance the biosynthesis of 7α-OH-Δ5P which in turn mediates
the stimulatory effect of PRL on locomotion.
EFFECT OF GABA ON NEUROSTEROID BIOSYNTHESIS
Gamma-aminobutyric acid (GABA) is the major neurotransmit-
ter in the CNS (Krnjevic and Schwartz, 1966; Meldrum, 1982;
Paredes and Agmo, 1992). In mammals, brain nuclei that express
steroidogenic enzymes (Tsutsui et al., 1999; Do Rego et al., 2009)
are innervated by GABAergic nerve ﬁbers (Tappaz et al., 1983;
Sakaue et al., 1988) and are also enriched with GABAA receptors
(De Montis et al., 1981; McDonald and Mascagni, 1996; Bäck-
berg et al., 2004), suggesting that GABA may regulate the activity
of steroidogenic nerve cells. As a matter of fact, pharmacological
studies have shown that administration of the GABA synthesis
inhibitor isoniazid induces an increase of endogenous Δ5P and P
in the rat brain (Barbaccia et al., 1996). In contrast, in rat retinal
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ganglion cells,GABA, acting throughGABAA receptors, stimulates
the biosynthesis of Δ5P (Guarneri et al., 1995).
The effect and mechanism of action of GABA in the control
of neurosteroidogenesis has been mainly investigated in non-
mammalian vertebrate models. Indeed, in amphibians as in mam-
mals, a rich GABAergic innervation (Franzoni and Morino, 1989;
Hollis and Boyd, 2005) and a dense accumulation of GABAA
receptor subunits (Aller et al., 1997) have been observed in hypo-
thalamic regions which contain steroidogenic neurons (Mensah-
Nyagan et al., 1994, 1999; Tsutsui et al., 1999; Do Rego et al.,
2009). In the frogRana esculenta,double labeling experiments have
shown the presence of GABAA receptor α3 and β2/β3 subunit-like
immunoreactivity in 3β-HSD-expressing cell bodies (Figure 1A)
in the Poa, the posterior tuberculum, the nucleus of the periven-
tricular organ, and the ventral and dorsal hypothalamic nuclei
of the hypothalamus (Do Rego et al., 2000) suggesting that, in
amphibians as in mammals, GABA may play a role in the control
of neurosteroid biosynthesis. In agreement with this hypothesis,
GABA has been shown to inhibit in a dose-dependent manner
de novo biosynthesis of various neurosteroids including 17OH-
Δ5P, P, 17OH-P, and DHEA, by frog hypothalamic explants (Do
Rego et al., 2000). The inhibitory effect of GABA on neuros-
teroid production is mimicked by the GABAA receptor agonist
muscimol and is blocked by the selective GABAA receptor antag-
onists bicuculline and SR95531, but is not affected by the GABAB
receptor agonist baclofen (Do Rego et al., 2000). The observation
that bicuculline and SR95531 induce on their own a signiﬁcant
stimulation of steroid formation suggests that endogenous GABA
exerts a tonic inhibitory control on neurosteroid-producing neu-
rons (Do Rego et al., 2000). These data indicate that GABA
inhibits the biosynthesis of neurosteroids through activation of
GABAA receptors (Figure 1D). Since several neuroactive steroids
are potent allosteric regulators of GABAA receptor function in
amphibians (Le Foll et al., 1997a,b; Hollis et al., 2004) as in mam-
mals (Majewska, 1992; Belelli and Lambert, 2005; Belelli et al.,
2006), these observations reveal the existence of an ultrashort
feedback loop through which certain neurosteroids may regulate
their own production via modulation of GABAA receptor activity
(Figure 1D).
EFFECT OF ENDOZEPINES ON NEUROSTEROID
BIOSYNTHESIS
The term endozepines designates a family of endogenous peptides
that act as natural ligands of CBRs and peripheral-type benzodi-
azepine receptors also called translocator protein (TSPO; Tonon
et al., 2006). The occurrence of endozepines has been reported
in the CNS of all classes of vertebrates including ﬁsh (Malagon
et al., 1992b; Matsuda et al., 2007), amphibians (Malagon et al.,
1992a; Lihrmann et al., 1994), birds (Todaro et al., 1991; Rose
et al., 1992), and mammals (Alho et al., 1989; Tonon et al., 1990;
Tong et al., 1991; Malagon et al., 1993). The endozepine family
encompasses diazepam-binding inhibitor (DBI),an 86-amino acid
polypeptide (Guidotti et al., 1983), and its processing products the
triakontatetraneuropeptide (TTN) and the octadecaneuropeptide
(ODN; Ferrero et al., 1984; Slobodyansky et al., 1989). TTN is a
selective ligand of TSPO (Slobodyansky et al., 1989; Papadopou-
los et al., 2006) while ODN acts as an inverse agonist of CBRs
FIGURE 1 | Effect of GABA and the octadecaneuropeptide ODN on
neurosteroid biosynthesis. (A) Immunohistochemical localization of
3β-HSD-like immunoreactivity (red) and GABAA receptor β2/β3 subunit-like
immunoreactivity (green) in the posterior tuberculum (PT) of the frog brain.
3β-HSD-positive neurons that possess GABAA receptor β2/β3 subunits
appear in yellow. (B) Immunohistochemical localization of 3β-HSD-like
immunoreactivity in the dorsal hypothalamic nucleus (DH; green). (C)
Consecutive section to B showing the immunohistochemical localization of
ODN-like immunoreactivity in glial cells bordering the third ventricle (red).
The contours of two 3β-HSD-positive neurons labeled in B are shown. For
details regarding antibodies and immunohistochemical procedures, see
references by Malagon et al. (1992a) and Do Rego et al. (2000, 2001). In
brief, polyclonal antibodies raised in rabbit were used to label
3β-HSD-containing neurons, a mouse monoclonal antibody was used to
label GABAA receptor β2/β3 subunit-expressing cells, and polyclonal
antibodies raised in rabbit were used to label ODN-immunoreactive glial
cells. Scale bars: 10μm. (D) Schematic drawing depicting the effects of
GABA and ODN on steroidogenic neurons. GABA acting through GABAA
receptors, inhibits the biosynthesis of neurosteroids, while the endozepine
ODN, released by glial ﬁbers, acting as an inverse agonist on central-type
benzodiazepine receptors (CBR), stimulates the biosynthesis of 17OH-Δ5P,
DHEA, 17OH-P, and P. Neurosteroids, released by these neurons, may in
turn modulate allosterically the activity of the GABAA receptor and thus
control their own biosynthesis.
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(Ferrero et al., 1984). Endozepines have been shown to regu-
late steroid secretion by adrenocortical cells (Yanagibashi et al.,
1989; Papadopoulos, 1993; Lesouhaitier et al., 1996, 1998) and
Leydig cells (Papadopoulos et al., 1990, 1991a,b; Garnier et al.,
1993, 1994; Duparc et al., 2003). Concurrently, it has been found
that TTN stimulates Δ5P biosynthesis by isolated mitochondria
from C6 glioma cells (Papadopoulos et al., 1992) indicating that
endozepines may be involved in the regulation of neurosteroid
production.
The distribution of endozepines has been investigated in the
brain of mammals and amphibians by in situ hybridization and
immunohistochemistry. In the rat brain, DBI mRNA is expressed
in various glial cell populations of the ependyma, area postrema,
and cerebellum (Alho et al., 1988; Tong et al., 1991; Bürgi et al.,
1999). In rat, monkey, and human, endozepine immunoreactivity
is found in astrocytes in the arcuate nucleus of the hypothala-
mus, ependymocytes bordering the third ventricle, tanycytes in
the median eminence, pituicytes in the neurohypophysis, and
Bergman cells in the cerebellum (Slobodyansky et al., 1992;
Malagon et al., 1993; Alho et al., 1995; Yanase et al., 2002). In
the frog R. esculenta, DBI mRNA and ODN-like immunoreactiv-
ity are present in radial glial cells of the periventricular systems of
the diencephalon and rhombencephalon (Malagon et al., 1992a;
Lihrmann et al., 1994). Immunolabeling of consecutive sections
revealed that, in the Poa, the dorsal and ventral hypothalamic
nuclei, the nucleus of the periventricular organ, and the posterior
tuberculum of the frog brain, ODN-immunoreactive ependymo-
cytes project toward 3β-HSD-positive perikarya (Do Rego et al.,
2001; Figures 1B,C). These neuroanatomical observations led us
to investigate the possible effects of endozepines on neurosteroid
biosynthesis in the diencephalon of amphibians.
Incubation of frog hypothalamic slices with graded concentra-
tions of human and rat ODN induces a dose-dependent stimu-
lation of the conversion of [3H]Δ5P into Δ4-3-ketosteroids and
Δ5-3β-hydroxysteroids in vitro (Do Rego et al., 2001). The bio-
logical activity of ODN is borne by the C-terminal portion of
the peptide (Do Rego et al., 2007b) whose sequence has been
strongly preserved across vertebrate species (Mocchetti et al., 1986;
Lihrmann et al., 1994; Tonon et al., 2006). The stimulatory action
of ODN on neurosteroid biosynthesis is mimicked by β-carbolines
that act as inverse agonists of CBR, and is blocked by the CBR
antagonist ﬂumazenil (DoRego et al., 2001). The fact that ﬂumaze-
nil alone inhibits the formation of neurosteroids supports the view
that ODN plays a physiological role as an endogenous positive
modulator of CBR (Do Rego et al., 2001; Figure 1D).
In intactmammalian endocrine cells,TTN stimulates the secre-
tion of glucocorticoids (Yanagibashi et al., 1989; Papadopoulos
et al., 1991a) and testosterone (Garnier et al., 1993; Duparc et al.,
2003). TTN also stimulates steroidogenesis by mitochondria iso-
lated fromadrenocortical and testicular Leydig cells (Besman et al.,
1989; Yanagibashi et al., 1989; Papadopoulos et al., 1991a). In
frog adrenal tissue,TTN stimulates corticosterone and aldosterone
secretion in vitro (Lesouhaitier et al., 1996, 1998). Since TSPO
is expressed not only in peripheral organs but also in the CNS
(Braestrup and Squires, 1977; Benavides et al., 1983a,b; Anholt
et al., 1984; Richards and Möhler, 1984; Gehlert et al., 1985), these
observations suggest that TTN may be involved in the regulation
of neurosteroidogenesis. To test this hypothesis, we have investi-
gated the effect of TTN on the biosynthesis of steroids in the brain
of amphibians.
Double labeling experiments have shown the presence of
TSPO-like immunoreactivity in steroidogenic neurons of the frog
Poa and dorsal hypothalamus (Do Rego et al., 1998; Figure 2A).
Exposure of frog hypothalamic fragments to synthetic human
TTN causes a concentration-dependent stimulation of the con-
version of [3H]Δ5P into 17OH-Δ5P and 17OH-P (Do Rego
et al., 1998). The TSPO agonist Ro5-4864 mimics the stimula-
tory effect of TTN while the TSPO antagonist PK11195 inhibits
TTN-induced steroid production. In contrast, the action of TTN
is not impaired by ﬂumazenil, indicating that TTN acts speciﬁ-
cally throughTSPO to activate neurosteroid biosynthesis (DoRego
et al., 1998; Figure 2B).
The fact that ODN and TTN, acting via CBR and TSPO,
respectively, stimulate the formation of a number of neurosteroids
suggests that endozepines should play multiple functions. Indeed,
in vivo studies indicate that endozepines, like neurosteroids, exert
numerous behavioral effects. In particular, endozepines induce
anxiety (Guidotti, 1991; Garcia de Mateos-Verchere et al., 1999),
increase aggressivity (Guidotti et al., 1983; Ferrero et al., 1984;
Kavaliers and Hirst, 1986; Guidotti, 1991), and possess anti-
convulsant properties (Garcia de Mateos-Verchere et al., 1999).
In addition, endozepines are potent anorexigenic neuropeptides
(Garcia de Mateos-Verchere et al., 2001; Do Rego et al., 2007).
Since endozepines and neurosteroids are involved in the control of
the same behavioral processes, it is conceivable that neurosteroids
can mediate some of the neurobiological effects of endozepines.
EFFECTS OF VASOTOCIN AND MESOTOCIN ON
NEUROSTEROID BIOSYNTHESIS
Anatomical studies support the existence of neurochemical com-
munication between steroidogenic neurons on the one hand, and
neurons producing either arginine vasopressin (AVP) and oxy-
tocin (OXT) in mammals or their orthologs arginine vasotocin
(AVT) and mesotocin (MT) in submammalian vertebrates on the
other hand. For instance, in birds, AVT-immunoreactive ﬁbers
innervate aromatase-expressing neurons in the preoptic nucleus
and the lateral septum (Viglietti-Panzica et al., 1994; Balthazart,
1997). In the brain of amphibians, AVT- and/or MT-containing
ﬁbers project in the vicinity of 3β-HSD- and P450C17-positive
neurons (Do Rego et al., 2006; Figure 3A). In addition, the Poa,
the dorsal and ventral hypothalamic nuclei, the suprachiasmatic
nucleus, the posterior tuberculum, the nucleus of the periventric-
ular organ, and the ventral part of the magnocellular preoptic
nucleus of the frog diencephalon that contain the major popula-
tions of steroidogenic neurons are also enriched withAVP and MT
receptormRNAs.These close neuroanatomical relationships ledus
to investigate the possible effects of AVT and MT on neurosteroid
biosynthesis in amphibians.
Static incubation of frog hypothalamic explants with AVT or
MT stimulates the biosynthesis of 17OH-Δ5P, P, 17OH-P, and
DHEA in a concentration-dependent manner (Do Rego et al.,
2006). This stimulatory effect is observed within the ﬁrst 30-min,
indicating that AVT and MT act at the post-translational level,
possibly by activating phosphorylation of steroidogenic enzymes.
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FIGURE 2 | Effect of the triakontatetraneuropeptide (TTN) on
neurosteroid biosynthesis. (A) Immunohistochemical localization of
3β-HSD-like immunoreactivity (red) and translocator protein (TSPO)-like
immunoreactivity (green) in the anterior preoptic area (Poa) of the frog
brain. 3β-HSD-positive neurons that possessTSPO appear in yellow. For
details regarding antibodies and immunohistochemical procedures, see
reference by Do Rego et al. (1998). In brief, polyclonal antibodies raised in
rabbit were used to label 3β-HSD-containing neurons, and polyclonal
antibodies raised in chicken were used to label theTSPO-expressing cells.
Scale bars: 10μm. (B) Schematic drawing depicting the effect of TTN on
steroidogenic neurons. TTN, acting throughTSPO, stimulates the
biosynthesis of 17OH-Δ5P, DHEA, and 17OH-P.
FIGURE 3 | Effect of vasotocin (AVT) and mesotocin (MT) on
neurosteroid biosynthesis. (A) Immunohistochemical localization of
P450C17-like immunoreactivity (red) and AVT-like immunoreactivity (green) in
the medial amygdala (MA) of the frog brain. AVT-containing nerve endings
are located in close proximity of P450C17-expressing neurons. For details
regarding antibodies and immunohistochemical procedures, see reference
by Do Rego et al. (2006). In brief, polyclonal antibodies raised in rabbit were
used to label 3β-HSD-or P450C17-containing neurons, and a mouse
monoclonal antibody was used to label AVT-immunoreactive ﬁbers. Scale
bars: 10μm. (B) Schematic drawing depicting the effects of AVT and MT on
steroidogenic neurons. AVT acting through a V1a-like receptor, and MT
acting through an MT receptor, stimulate the biosynthesis of 17OH-Δ5P,
DHEA, 17OH-P, and P.
Themammalian peptidesAVP andOXT also induce a dose-related
stimulation of neurosteroid biosynthesis (Do Rego et al., 2006).
Pharmacological studies conducted with speciﬁc AVT and MT
agonists and antagonists revealed that the effect of AVT and MT
are mediated through V1a and MT receptors, respectively (Do
Rego et al., 2006; Figure 3B). These observations are in agreement
with the intense expression of V1a and MT receptor mRNAs in the
hypothalamic nuclei that contain neurosteroidogenic neurons (Do
Rego et al., 2006). Interestingly, in frog adrenocortical cells, AVT
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is also a potent stimulator of corticosteroid secretion although,
in this latter case, AVT acts via V2 receptors (Larcher et al., 1989,
1992).
In vertebrates, AVP and related peptides exert a vast array of
biological effects in the CNS (De Wied et al., 1993; Reghunan-
danan et al., 1998). For instance, in mammals, AVP enhances
learning and memory (Alescio-Lautier and Soumireu-Mourat,
1998; Croiset et al., 2000; Engelmann et al., 2000; Engelmann,
2008) and increases aggressivity and anxiety-like behaviors (Ferris
et al., 1997;Everts andKoolhaas,1999;Heinrichs andDomes,2008;
Amikishieva et al., 2011; Mak et al., 2011; Meyer-Lindenberg et al.,
2011). In birds, depending of the species, AVT increases or attenu-
ates aggressive behavior (Goodson et al., 2004, 2009; Dewan et al.,
2011). In amphibians, AVT stimulates vocalization and courtship
behavior (Woolley et al., 2004;Moore et al., 2005; Thompson et al.,
2008; Kikuyama et al., 2009). Certain neurosteroids also affect cog-
nitive and mnemonic functions, aggressiveness and sexual activity
(Frye, 2001; Vallée et al., 2001; Darnaudery et al., 2002; MacKen-
zie et al., 2007; Morrow, 2007). It thus appears that some of the
behavioral effects of AVP/AVTmaybe ascribed to their stimulatory
action on neurosteroid biosynthesis.
EFFECT OF NEUROPEPTIDE Y ON NEUROSTEROID
BIOSYNTHESIS
Hydroxysteroid sulfotransferase (HST) catalyzes the transfer of
a sulfate moiety from 3′-phosphoadenosine 5′-phosphosulfate
(PAPS, a universal donor of sulfate radical) on the 3-hydroxyl
group of steroids (Klaassen and Boles, 1997; Strott, 2002). While
the presence of HST-containing neurons has been clearly demon-
strated in the amphibian hypothalamus (Beaujean et al., 1999;
Vaudry et al., 2011), the existence of HST in the brain of mammals
is still a matter of debate (Geese and Raftogianis, 2001; Shimada
et al., 2001; Shimizu et al., 2003; Kohjitani et al., 2006). Neuropep-
tide Y (NPY) is one of the most widely distributed biologically
active peptides in the CNS of vertebrates (Allen et al., 1983; De
Quidt andEmson,1986; Bons et al., 1990;Danger et al., 1990, 1991;
Aste et al., 1991; Hendry, 1993) and NPY, like sulfated neuros-
teroids, exerts a wide range of neurobiological activities (Dumont
and Quirion, 2006).
In frog, the Poa and the magnocellular preoptic nucleus where
HST-positive cell bodies are located (Beaujean et al., 1999;DoRego
et al., 2009) are abundantly innervated by NPY-immunoreactive
ﬁbers (Danger et al., 1985), suggesting that NPY could play a
role in the regulation of HST-expressing neurons. In support
of this hypothesis, double labeling experiments revealed that, in
the frog diencephalon, numerous NPYergic axon terminals are
apposed onto HST-containing perikarya (Beaujean et al., 2002;
Figure 4A). In addition, the mRNAs encoding the Y1 and Y5 NPY
receptor subtypes are expressed in the Poa and the magnocellu-
lar preoptic nucleus (Beaujean et al., 2002). Incubation of frog
hypothalamic tissue with [3H]Δ5P or [3H]DHEA as steroid pre-
cursors and [35S]PAPS as a sulfate donor leads to the biosynthesis
of [3H, 35S]Δ5PS or [3H, 35S]DHEAS, respectively, conﬁrming
the existence of a biologically active form of HST in the amphib-
ian brain (Beaujean et al., 1999). Synthetic frog NPY (Chartrel
et al., 1991) causes a concentration-dependent inhibition of the de
novo formation of Δ5PS and DHEAS (Beaujean et al., 2002). The
FIGURE 4 | Effect of neuropeptideY (NPY) on neurosteroid
biosynthesis. (A) Immunohistochemical localization of hydroxysteroid
sulfotransferase (HST)-like immunoreactivity (red) and NPY-like
immunoreactivity (green) in the dorsal part of the magnocellular preoptic
nucleus (Mgd) of the frog brain. NPY-containing nerve endings are located
in close proximity of HST-expressing neurons. For details regarding
antibodies and immunohistochemical procedures, see reference by
Beaujean et al. (2002). In brief, polyclonal antibodies raised in rabbit were
used to label HST-containing neurons, and polyclonal antibodies raised in
sheep were used to label NPY-immunoreactive ﬁbers. Scale bars: 20μm.
(B) Schematic drawing depicting the effect of NPY on steroidogenic
neurons. NPY acting throughY1 receptors negatively coupled to adenylyl
cyclase, inhibits the biosynthesis of Δ5PS and DHEAS.
inhibitory effect of NPY is suppressed by the Y1 receptor antag-
onist BIBP3226 while the Y2 receptor antagonist NPY(13–36) is
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totally inactive (Beaujean et al., 2002). The fact that the Y1 recep-
tor antagonist per se slightly increases the biosynthesis of Δ5PS
and DHEAS reveals that endogenous NPY likely acts as a phys-
iological modulator of the formation of sulfated neurosteroids
(Beaujean et al., 2002). These data, together with the observa-
tion that Y1 receptor mRNA is expressed in the Poa and the
dorsal magnocellular nucleus, provide strong evidence for a Y1-
mediated inhibitory action of NPY on the biosynthesis of sulfated
neurosteroids (Figure 4B).
Neuropeptide Y and sulfated neurosteroids are known to reg-
ulate the same behavioral activities including response to novelty
(von Horsten et al., 1998; Tasan et al., 2009), feeding and sati-
ety (Kalra and Kalra, 2004a,b; Ramos et al., 2005; Beck, 2006;
Ueno et al., 2008), and reproductive behavior (Wehrenberg et al.,
1989). NPY and sulfated neurosteroids are also implicated in the
physiopathology of cognitive disorders, pain, epilepsy, anxiety,
and depression (Engel and Grant, 2001; Rupprecht and Holsboer,
2001; Dumont and Quirion, 2006; Gibbs et al., 2006; Reddy, 2010;
Thorsell, 2010; Nguyen et al., 2011). The fact that NPY reduces
the biosynthesis of sulfated neurosteroids would thus indicate
that some of the neurophysiological activities of NPY could be
attributed to inhibition of HST activity.
CONCLUDING REMARKS
Studies conducted over the last decade have shown that the biosyn-
thesis of neurosteroids is ﬁnely regulated by neurotransmitters
(melatonin, GABA), pituitary hormones (prolactin), and various
neuropeptides (ODN, TTN, AVT, MT, NPY). Several projects are
currently in progress and there is little doubt that additional factors
involved in the control of neurosteroid formationwill be identiﬁed
in the near future. As illustrated in the present report, most of the
studies aimed at identifying the neurochemical regulation of neu-
rosteroid biosynthesis have been conducted in non-mammalian
models, mainly birds and amphibians. It will be now essential to
examine whether the same mechanisms are operating in the brain
of mammals and to look for their potential physiopathological
signiﬁcance. Little is currently known regarding the molecular
mechanisms implicated in the regulation of neurosteroid biosyn-
thesis. In particular, it has to be determined whether the neu-
roendocrine factors controlling neurosteroid production act at the
transcriptional level to regulate the expression of the genes encod-
ing the steroidogenic enzymes or at the post-translational level,
e.g., to modulate the phosphorylation and thus the activity of
these enzymes. The fact that neurosteroids are usually implicated
in the same biological processes as the neuroendocrine factors
which regulate their biosynthesis strongly suggests that some of
the neurophysiological and behavioral activities of these latter fac-
tors could be mediated by neurosteroids. To test this hypothesis, it
will be necessary to investigate whether speciﬁc activities of these
regulatory factors are impaired in conditional KO mice lacking
selectively expression of steroidogenic enzymes in the brain. The
neuroendocrine regulation of neurosteroid biosynthesis by neu-
rotransmitters, neuropeptides, and hormonal factors is currently
an emerging theme that will undoubtedly ﬂourish in the years to
come.
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